A new add-on blood test called the FAP-Index may help accurately identify serious liver scarring in people with metabolic…
Articles by Marisa Wexler, MS
Daily treatment with Orsobio’s oral candidate TLC-2716 reduces fat levels in both the blood and liver in overweight adults…
Infants with cystic biliary atresia (CBA) tend to undergo standard Kasai surgery earlier than those with other forms of…
A new test that uses a tiny drop of blood collected from a finger prick and returns results in about…
Health Canada has approved Mirum Pharmaceuticals’ oral therapy Livmarli (maralixibat) for cholestatic pruritus — that is, itching due…
An oral tablet formulation of Livmarli (maralixibat) is now approved in Canada to treat pruritus (itching) caused by…
Dosing has begun in a Phase 1/2 clinical trial testing CRMA-1001, Nchroma Bio’s experimental epigenetic therapy being studied as…
Huahui Health‘s Libevitug has become the first approved treatment for chronic hepatitis D virus (HDV) infection in China. The…
People who are exposed to more sunlight over their lifetimes are less likely to develop primary biliary cholangitis (PBC),…
A combination of aerobic exercise and resistance exercise is most effective for reducing liver fat, according to a review of…